Another pharmaceutical company has recalled blood pressure medication over illness risk

Another pharmaceutical company is recalling a blood pressure medication because it can increase the risk of cancer.

The FDA announced that Lupin Pharmaceuticals recalled four lots of Quinapril Tablets because they had too much of N-Nitroso- Quinapril.

There is a marked medication.

Quinapril tablets are 20mg. The expired date is April 23, 2023.

The Quinapril Tablets have an expired date of December 2022.

There are 90-count bottles for the tablets. They were distributed across the country. Businesses are being notified of the recall after the company stopped marketing the medication.

There were two lots of Quinapril that were recalled.

Blood pressure medication has been recalled for having too much of an impurity.

What is nitrosamine and N-Nitroso-Quinapril?

The FDA says that nitrosamines are found in water and food that everyone is exposed to.

If people are exposed to it over a long period of time, it may increase the risk of cancer.

What to do if you have the medication?

Consumers are not in immediate danger because no illnesses have been reported from this recall.

The FDA advises anyone with questions on the recall to call Inmar. Mondays through Fridays. The medication must be returned for reimbursement.

The FDA has a MedWatch Adverse event reporting program.

The report can be submitted online at www.fda.gov/medwatch/report.htm.

You can request a reporting form online at www.fda.gov/medwatch/getforms.htm or you can fax it to 800-FDA-0178.

The FDA has more information on how to report a problem.